These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37737187)

  • 1. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.
    Geng Y; Long X; Zhang Y; Wang Y; You G; Guo W; Zhuang G; Zhang Y; Cheng X; Yuan Z; Zan J
    J Transl Med; 2023 Sep; 21(1):652. PubMed ID: 37737187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson's disease mice.
    Yu Z; Huang L; Xia Y; Cheng S; Yang C; Chen C; Zou Z; Wang X; Tian X; Jiang X; Zhou L
    Neurosci Lett; 2022 Nov; 791():136907. PubMed ID: 36209975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early B Cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: An experimental study.
    Hu W; Wang M; Sun G; Zhang L; Lu H
    Cell Signal; 2024 Jun; 118():111139. PubMed ID: 38479556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-Regulation of m6A mRNA Methylation Is Involved in Dopaminergic Neuronal Death.
    Chen X; Yu C; Guo M; Zheng X; Ali S; Huang H; Zhang L; Wang S; Huang Y; Qie S; Wang J
    ACS Chem Neurosci; 2019 May; 10(5):2355-2363. PubMed ID: 30835997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A-NRF2-dependent manner.
    Pang P; Zhang S; Fan X; Zhang S
    Cell Biol Int; 2024 Apr; 48(4):431-439. PubMed ID: 38180302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m
    Gong X; Huang M; Chen L
    CNS Neurosci Ther; 2024 Mar; 30(3):e14441. PubMed ID: 37735974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Parkinson's disease model with human umbilical cord mesenchymal stem cell-derived exosomes loaded with BDNF.
    Wang CC; Hu XM; Long YF; Huang HR; He Y; Xu ZR; Qi ZQ
    Life Sci; 2024 Nov; 356():123014. PubMed ID: 39182566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
    Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
    Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic m6A modification regulates local translation of mRNA in axons.
    Yu J; Chen M; Huang H; Zhu J; Song H; Zhu J; Park J; Ji SJ
    Nucleic Acids Res; 2018 Feb; 46(3):1412-1423. PubMed ID: 29186567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson's disease model via regulation of Nox4/ROS/Nrf2 signaling.
    He S; Wang Q; Chen L; He YJ; Wang X; Qu S
    J Transl Med; 2023 Oct; 21(1):747. PubMed ID: 37875930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite.
    Bai L; Tang Q; Zou Z; Meng P; Tu B; Xia Y; Cheng S; Zhang L; Yang K; Mu S; Wang X; Qin X; Lv B; Cao X; Qin Q; Jiang X; Chen C
    Toxicol Sci; 2018 Oct; 165(2):431-446. PubMed ID: 29982692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL14 is decreased and regulates m
    He H; Zhang Q; Liao J; Lei J; Luo M; Huang J; Chen M; Shen Y; Wang J; Xu P; Xiao Y
    J Neurochem; 2023 Aug; 166(3):609-622. PubMed ID: 37309980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson's disease.
    Li Y; Li Z; Gu J; Xu X; Chen H; Gui Y
    Neurosci Lett; 2022 Feb; 771():136414. PubMed ID: 34954117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
    Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
    Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
    Jing YX; Li HX; Yue F; Li YM; Yu X; He JJ; Zhang XH
    Gynecol Endocrinol; 2023 Oct; 39(1):2276167. PubMed ID: 37931646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell-derived exosomes altered neuron cholesterol metabolism via Wnt5a-LRP1 axis and alleviated cognitive impairment in a progressive Parkinson's disease model.
    Xu X; Li Z; Zuo H; Chen H; Gui Y
    Neurosci Lett; 2022 Sep; 787():136810. PubMed ID: 35870714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
    Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y
    CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.